Search

Your search keyword '"Pan, Catherine"' showing total 10 results
Start Over Author "Pan, Catherine" Publisher wiley
10 results on '"Pan, Catherine"'

1. An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression

Author

Yang, Li, primary, Stewart, Tessandra, additional, Shi, Min, additional, Pottiez, Gwenael, additional, Dator, Romel, additional, Wu, Rui, additional, Aro, Patrick, additional, Schuster, Robert J., additional, Ginghina, Carmen, additional, Pan, Catherine, additional, Gao, Yuqian, additional, Qian, Weijun, additional, Zabetian, Cyrus P., additional, Hu, Shu-Ching, additional, Quinn, Joseph F., additional, and Zhang, Jing, additional

Published
2017
Full Text
View/download PDF

5. Glycoproteomics in neurodegenerative diseases

Author

Hwang, Hyejin, primary, Zhang, Jianpeng, additional, Chung, Kathryn A., additional, Leverenz, James B., additional, Zabetian, Cyrus P., additional, Peskind, Elaine R., additional, Jankovic, Joseph, additional, Su, Zhen, additional, Hancock, Aneeka M., additional, Pan, Catherine, additional, Montine, Thomas J., additional, Pan, Sheng, additional, Nutt, John, additional, Albin, Roger, additional, Gearing, Marla, additional, Beyer, Richard P., additional, Shi, Min, additional, and Zhang, Jing, additional

Published
2009
Full Text
View/download PDF

6. Identification of proteins in human substantia nigra

Author

Kitsou, Efstathia, primary, Pan, Sheng, additional, Zhang, JianPeng, additional, Shi, Min, additional, Zabeti, Aram, additional, Dickson, Dennis W., additional, Albin, Roger, additional, Gearing, Marla, additional, Kashima, Daniel T., additional, Wang, Yan, additional, Beyer, Richard P., additional, Zhou, Yong, additional, Pan, Catherine, additional, Caudle, W. Michael, additional, and Zhang, Jing, additional

Published
2008
Full Text
View/download PDF

7. Proteomic Identification of Novel Proteins in Cortical Lewy Bodies

Author

Leverenz, James B., primary, Umar, Imran, additional, Wang, Qing, additional, Montine, Thomas J., additional, McMillan, Pamela J., additional, Tsuang, Debby W., additional, Jin, Jinghua, additional, Pan, Catherine, additional, Shin, Jenny, additional, Zhu, David, additional, and Zhang, Jing, additional

Published
2007
Full Text
View/download PDF

10. Glycoproteomics in neurodegenerative diseases.

Author

Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, and Zhang J

Subjects
Amino Acid Sequence, Glycoproteins cerebrospinal fluid, Glycosylation, Humans, Mass Spectrometry trends, Molecular Sequence Data, Neurodegenerative Diseases cerebrospinal fluid, Neurodegenerative Diseases diagnosis, Proteomics trends, Glycoproteins analysis, Glycoproteins metabolism, Mass Spectrometry methods, Neurodegenerative Diseases metabolism, Proteomics methods
Abstract

Protein glycosylation regulates protein function and cellular distribution. Additionally, aberrant protein glycosylations have been recognized to play major roles in human disorders, including neurodegenerative diseases. Glycoproteomics, a branch of proteomics that catalogs and quantifies glycoproteins, provides a powerful means to systematically profile the glycopeptides or glycoproteins of a complex mixture that are highly enriched in body fluids, and therefore, carry great potential to be diagnostic and/or prognostic markers. Application of this mass spectrometry-based technology to the study of neurodegenerative disorders (e.g., Alzheimer's disease and Parkinson's disease) is relatively new, and is expected to provide insight into the biochemical pathogenesis of neurodegeneration, as well as biomarker discovery. In this review, we have summarized the current understanding of glycoproteins in biology and neurodegenerative disease, and have discussed existing proteomic technologies that are utilized to characterize glycoproteins. Some of the ongoing studies, where glycoproteins isolated from cerebrospinal fluid and human brain are being characterized in Parkinson's disease at different stages versus controls, are presented, along with future applications of targeted validation of brain specific glycoproteins in body fluids., (Copyright 2009 Wiley Periodicals, Inc.)

Published
2010
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results